Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thermo Fisher Scientific Inc. announced it will invest $97 million to expand its clinical research operations in Richmond, Virginia. The facilities, which include laboratory operations acquired with the purchase of PPD, Inc. in December 2021, will ...
read more
OcyonBio announced a manufacturing and operations agreement to develop biosimilar drug product facilities for Biosimilar Solutions, Inc. OcyonBio is creating an advanced therapy contract development, manufacturing organization (CDMO) that provides ...
read more
Almac Pharma Services, a member of the Almac Group, has expanded its state-of-the-art Ultra-Low Temperature commercial packaging, labelling and distribution solutions to support the launch of Advanced Therapy Medicinal Products (ATMPs) from its ...
read more
Leidos was recently awarded a new prime contract to provide biomedical preclinical and development capabilities to support the National Institute of Allergy and Infectious Diseases (NIAID).
read more
Emmes has acquired Casimir, a U.S.-based CRO. Casimir has experience in more than 20 rare diseases and has worked with regulators, sponsors and patients to develop outcome measures that capture the nuances of disease progression and treatment benefit...
read more
Stevanato Group announced the acquisition of a facility in Zhangjiagang for a new plant where the Company expects to begin renovations in the spring 2022, as part of the latest phase of its expansion in China.
read more
Wednesday, March 09, 2022
H Clinical announced that the company is expanding logistics service capabilities to support decentralized clinical trials (DCTs) in emerging markets throughout Latin America. Coordinated logistics and depots better facilitate multi-site and multi-...
read more
Wednesday, March 09, 2022
Celerion has announced completion of additions to its research capacity and services. This includes the opening of a new Screening and Return Center, upgraded pharmacy compounding suites, expanded Absorption, Distribution, Metabolism and Excretion (...
read more
Wednesday, March 09, 2022
PharmaLex Group has announced a merger with Italy-based EBMA Consulting, a specialist consultancy company focused on strategic pricing, market access and health economics services for the life sciences.
read more
Lonza announced the completion of a laboratory expansion at its active pharmaceutical ingredients (API) manufacturing site at Nansha, China. The expansion focused on extending the capabilities and capacity of development laboratories and kilogram-...
read more
Orbit Discovery has announced the commencement of a partnership with WuXi AppTec, a global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry.
read more
Veristat, a global clinical research organization (CRO), announced the expansion and strengthening of its service capabilities by acquiring SFL (Solutions for Life Sciences). With headquarters in Basel, Switzerland and several European affiliates, ...
read more
Skye Bioscience has entered into an agreement with Novotech Health Holdings (“Novotech”), a leading full-service contract research organization (“CRO”) in Asia-Pacific, for its upcoming Phase 1 study in Australia of its SBI-100 drug candidate for the...
read more
Wednesday, March 02, 2022
Cambrex announced it is significantly expanding its existing biopharmaceutical testing services business. The expansion includes 11 additional cGMP laboratories at Cambrex's Durham, NC facility and broadens its service offering for large molecule and...
read more
Wednesday, March 02, 2022
Sterling Pharma Solutions has reached an agreement with Novartis to acquire its Ringaskiddy campus (Novartis Ringaskiddy Limited), near Cork, Ireland. Financial details of the sale, which is expected to close in Q4, 2022, have not been disclosed.
read more